Clinical Trials Directory

Trials / Conditions / Pleural Malignant Mesothelioma

Pleural Malignant Mesothelioma

8 registered clinical trials studyying Pleural Malignant Mesothelioma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of MT027 in Patients with Pleural Malignant Tumors
NCT06726564
Suzhou Maximum Bio-tech Co., Ltd.Phase 1
Active Not RecruitingPembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesoth
NCT03126630
National Cancer Institute (NCI)Phase 1 / Phase 2
UnknownConfocal Laser Endomicroscopy in Pleural Malignancies
NCT03290183
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)—
Active Not RecruitingPembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
NCT02959463
M.D. Anderson Cancer CenterPhase 1
TerminatedAccelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant
NCT02672033
Jonsson Comprehensive Cancer CenterN/A
Active Not RecruitingPembrolizumab in Treating Patients With Malignant Mesothelioma
NCT02399371
University of ChicagoPhase 2
CompletedAnti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
NCT01112293
Abramson Cancer Center at Penn MedicinePhase 2
Active Not RecruitingPemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleura
NCT01064648
National Cancer Institute (NCI)Phase 1 / Phase 2